Pulling SEC filings + quote and writing the call…

Virax Biolabs Group Ltd
Mixed signals in the latest filings.
Virax Biolabs Group Ltd shows limited reported revenue.
Sources: SEC EDGAR (CIK 0001885827, latest 6-K filed 2026-06-24) · EODHD · as of 6/27/2026, 6:14:12 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
€15/mo · cancel anytime
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1049 tracked peers · median